Free Trial
NASDAQ:TXMD

TherapeuticsMD Q2 2023 Earnings Report

TherapeuticsMD logo
$1.38 -0.03 (-1.94%)
Closing price 05/7/2025 03:52 PM Eastern
Extended Trading
$1.44 +0.06 (+4.07%)
As of 05/7/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TherapeuticsMD EPS Results

Actual EPS
-$0.24
Consensus EPS
-$0.07
Beat/Miss
Missed by -$0.17
One Year Ago EPS
N/A

TherapeuticsMD Revenue Results

Actual Revenue
$0.44 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

TherapeuticsMD Announcement Details

Quarter
Q2 2023
Time
Before Market Opens
Conference Call Date
Monday, August 14, 2023
Conference Call Time
7:00AM ET

Upcoming Earnings

TherapeuticsMD's Q1 2025 earnings is scheduled for Friday, May 9, 2025, with a conference call scheduled on Sunday, May 11, 2025 at 12:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

TherapeuticsMD Earnings Headlines

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)
Trump to redistribute trillions of dollars
Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be laughable if it wasn’t putting so many Americans’ financial futures at severe risk… That’s why, with the 100-day mark of Trump’s second term just days away, it’s time to shine a light on what’s really going on, because if you move your money out of the wrong places and into the right ones before it’s too late… …you could be one of the few who profits from this imminent trillion-dollar reset.
See More TherapeuticsMD Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TherapeuticsMD? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TherapeuticsMD and other key companies, straight to your email.

About TherapeuticsMD

TherapeuticsMD (NASDAQ:TXMD) operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

View TherapeuticsMD Profile

More Earnings Resources from MarketBeat